Lifecore Biomedical, Inc. \de\ SEC filings LFCR
Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| PREM14A | Filing | Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 29, 2026 | Sep 24, 2026 |
| DEFA14A | Additional proxy material | Sep 28, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 28, 2026 | Sep 27, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 2, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
| DEF 14A | Proxy statement | Apr 24, 2026 | Apr 24, 2026 |
| 10-KT | Transition report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K | Current report | Mar 5, 2026 | Mar 5, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Oct 31, 2025 | Oct 29, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| 424B3 | Prospectus | Sep 30, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2025 | Sep 22, 2025 |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2025 | — |
| S-3 | Shelf registration | Sep 23, 2025 | — |
| DEF 14A | Proxy statement | Sep 18, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Auditor change
|
Aug 18, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2025 | Aug 12, 2025 |
| S-8 | Employee stock plan registration | Aug 7, 2025 | — |
| 10-K | Annual report | Aug 7, 2025 | May 25, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 18, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Apr 10, 2025 | Apr 10, 2025 |
| 10-Q | Quarterly report | Apr 3, 2025 | Feb 23, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 3, 2025 | Apr 3, 2025 |
| DEF 14A | Proxy statement | Feb 27, 2025 | Feb 27, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 21, 2025 | Jan 21, 2025 |
| DEFA14A | Additional proxy material | Jan 17, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 17, 2025 | Jan 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 7, 2025 |
| 10-Q | Quarterly report | Jan 2, 2025 | Nov 24, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 2, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 26, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 21, 2024 | Nov 21, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 8, 2024 | Nov 7, 2024 |
| 424B3 | Prospectus | Oct 23, 2024 | — |
| EFFECT | Filing | Oct 22, 2024 | — |
| CORRESP | Letter to the SEC | Oct 18, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2024 | — |
| EFFECT | Filing | Oct 15, 2024 | — |
| S-8 | Employee stock plan registration | Oct 10, 2024 | — |
| S-8 | Employee stock plan registration | Oct 10, 2024 | — |
| S-1 | Registration statement | Oct 10, 2024 | — |
| POS AM | Filing | Oct 10, 2024 | — |
| 10-Q | Quarterly report | Oct 4, 2024 | Aug 25, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Oct 4, 2024 | Oct 3, 2024 |
| DEF 14A | Proxy statement | Sep 23, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 23, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Other events
|
Sep 12, 2024 | Sep 11, 2024 |
| 8-K |
Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Aug 29, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 26, 2024 | Aug 26, 2024 |
| 10-K | Annual report | Aug 26, 2024 | May 26, 2024 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Aug 21, 2024 | Aug 15, 2024 |
| NT 10-K | Filing | Aug 12, 2024 | May 26, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Feb 25, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Nov 26, 2023 |
| 10-Q | Quarterly report | Aug 9, 2024 | Aug 27, 2023 |
| DEFA14A | Additional proxy material | Aug 9, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jul 24, 2024 | Jul 18, 2024 |
| DEF 14A | Proxy statement | Jul 19, 2024 | May 28, 2023 |
| 8-K |
Current report
Exit or restructuring costs
|
Jul 12, 2024 | Jul 8, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 8, 2024 | May 28, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Jul 1, 2024 | Jun 28, 2024 |
| UPLOAD | Letter from the SEC | Jun 13, 2024 | — |
| 8-K |
Current report
Listing notice
|
Jun 7, 2024 | Jun 3, 2024 |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
May 22, 2024 | May 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 16, 2024 | May 16, 2024 |
| 8-K |
Current report
Material agreement, Listing notice
|
May 14, 2024 | May 8, 2024 |
| UPLOAD | Letter from the SEC | May 13, 2024 | — |
| 8-K |
Current report
Material agreement
|
May 8, 2024 | May 2, 2024 |
| 8-K |
Current report
Officer or director change
|
May 7, 2024 | May 1, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 30, 2024 | Apr 29, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 19, 2024 | Apr 15, 2024 |
| NT 10-Q | Filing | Apr 8, 2024 | Feb 25, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Auditor change
|
Mar 26, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 21, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2024 | Mar 20, 2024 |
| 10-K | Annual report | Mar 20, 2024 | May 28, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Feb 16, 2024 | Feb 13, 2024 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 12, 2024 | Jan 10, 2024 |
| NT 10-Q | Filing | Jan 10, 2024 | Nov 26, 2023 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jan 5, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Restatement
|
Oct 31, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 18, 2023 | Oct 12, 2023 |
| NT 10-Q | Filing | Oct 10, 2023 | Aug 27, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 31, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 22, 2023 | Aug 17, 2023 |
| NT 10-K | Filing | Aug 14, 2023 | May 28, 2023 |
| EFFECT | Filing | Jun 9, 2023 | — |
| 424B3 | Prospectus | Jun 9, 2023 | — |
| CORRESP | Letter to the SEC | Jun 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 6, 2023 | — |
| 10-Q | Quarterly report | Jun 2, 2023 | Feb 26, 2023 |
| 8-K |
Current report
Results of operations
|
Jun 1, 2023 | Jun 1, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
May 23, 2023 | May 22, 2023 |
| 8-K |
Current report
Officer or director change
|
May 2, 2023 | Apr 27, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Apr 14, 2023 | Apr 13, 2023 |
| UPLOAD | Letter from the SEC | Apr 14, 2023 | — |
| NT 10-Q | Filing | Apr 10, 2023 | Feb 26, 2023 |
| S-1 | Registration statement | Apr 6, 2023 | — |
| S-8 | Employee stock plan registration | Apr 6, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 6, 2023 | Apr 6, 2023 |
| 8-K/A | Amended current report | Mar 27, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 16, 2023 | Mar 16, 2023 |
| 10-Q | Quarterly report | Mar 16, 2023 | Nov 27, 2022 |
| 10-Q/A | Amended quarterly report | Mar 16, 2023 | Aug 28, 2022 |
| 10-K/A | Amended annual report | Mar 16, 2023 | May 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2023 | Feb 27, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Restatement
|
Feb 1, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 11, 2023 | Jan 11, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jan 10, 2023 | Jan 9, 2023 |
| NT 10-Q | Filing | Jan 9, 2023 | Nov 27, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Nov 25, 2022 | Nov 25, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 16, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Nov 7, 2022 | Nov 1, 2022 |
| 10-Q | Quarterly report | Oct 7, 2022 | Aug 28, 2022 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2022 | Oct 6, 2022 |
| DEF 14A | Proxy statement | Sep 19, 2022 | Sep 19, 2022 |
| 8-K |
Current report
Restatement
|
Sep 14, 2022 | Sep 13, 2022 |
| 10-K | Annual report | Sep 14, 2022 | May 29, 2022 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Sep 9, 2022 | Sep 2, 2022 |
| NT 10-K | Filing | Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 10, 2022 | Aug 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 2, 2022 | Jun 2, 2022 |
| 10-Q | Quarterly report | Apr 7, 2022 | Feb 27, 2022 |
| 8-K |
Current report
Results of operations
|
Apr 5, 2022 | Apr 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 24, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 10-Q | Quarterly report | Jan 7, 2022 | Nov 28, 2021 |
| 8-K |
Current report
Results of operations
|
Jan 5, 2022 | Jan 5, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 20, 2021 | Dec 14, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Dec 17, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 14, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Oct 26, 2021 | Oct 20, 2021 |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2021 | Oct 11, 2021 |
| 10-Q | Quarterly report | Oct 5, 2021 | Aug 29, 2021 |
| 8-K |
Current report
Results of operations
|
Sep 29, 2021 | Sep 29, 2021 |
| DEF 14A | Proxy statement | Aug 27, 2021 | Oct 20, 2021 |
| 10-K | Annual report | Jul 29, 2021 | May 30, 2021 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jul 28, 2021 | Jul 27, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 2, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2021 | May 17, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
May 5, 2021 | May 5, 2021 |
| 10-Q | Quarterly report | Apr 8, 2021 | Feb 28, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 7, 2021 | Apr 7, 2021 |
| UPLOAD | Letter from the SEC | Mar 10, 2021 | — |
| CORRESP | Letter to the SEC | Mar 8, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2021 | Mar 2, 2021 |
| 8-K |
Current report
Other events
|
Feb 24, 2021 | Feb 24, 2021 |
| CORRESP | Letter to the SEC | Feb 16, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Feb 2, 2021 | Jan 28, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 20, 2021 | Jan 15, 2021 |
| 10-Q | Quarterly report | Jan 7, 2021 | Nov 29, 2020 |
| 8-K |
Current report
Results of operations
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt, Regulation FD disclosure
|
Jan 5, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Oct 19, 2020 | Oct 14, 2020 |
| 10-Q | Quarterly report | Oct 7, 2020 | Aug 30, 2020 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Oct 6, 2020 | Sep 30, 2020 |
| DEF 14A | Proxy statement | Aug 31, 2020 | Oct 14, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 25, 2020 | Aug 24, 2020 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Aug 24, 2020 | Aug 20, 2020 |
| PRE 14A | Preliminary proxy statement | Aug 21, 2020 | Oct 14, 2020 |
| 10-K | Annual report | Aug 14, 2020 | May 31, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2020 | Aug 11, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 30, 2020 | Jul 23, 2020 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Jul 17, 2020 | Jul 15, 2020 |
| 8-K | Current report | Jun 29, 2020 | Jun 29, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2020 | Apr 1, 2020 |
| 10-Q | Quarterly report | Apr 3, 2020 | Feb 23, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change, Other events
|
Mar 25, 2020 | Mar 19, 2020 |
| 8-K/A |
Amended current report
Exit or restructuring costs
|
Mar 25, 2020 | Dec 27, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 28, 2020 | Feb 27, 2020 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 28, 2020 | Oct 15, 2019 |
| 10-Q | Quarterly report | Jan 2, 2020 | Nov 24, 2019 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Officer or director change
|
Jan 2, 2020 | Dec 27, 2019 |
| 8-K |
Current report
New debt, Other events
|
Oct 30, 2019 | Oct 25, 2019 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Oct 21, 2019 | Oct 15, 2019 |
| S-8 | Employee stock plan registration | Oct 16, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFCR (Nasdaq)
- Fiscal year ends
- May 25
- Incorporated in
- DE
- Headquarters
- Chaska, MN
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\ (until Nov 7, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.